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GALLIUM-67 IMAGING IN A PATIENT WITH PARACOCCIDIOIDOMYCOSIS: A CASE REPORT
Ana Beatriz Marinho de Jesus TEIXEIRA, Elba Cristina Sá de Camargo ETCHEBEHERE, Mariana Cunha Lopes de LIMA, Allan de Oliveira SANTOS, Bruno Cunha PIRES,
José Telmo VALENÇA JR., Celso Darío RAMOS & Edwaldo E. CAMARGO
SUMMARY
A 26 year-old female was admitted with abdominal pain, fever and weight loss. The clinical and laboratory investigations led to
the diagnosis of paracoccidioidomycosis. Gallium-67 whole body images correlated well with the clinical course of the disease and
with the patient’s prognosis.
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INTRODUCTION
Paracoccidioidomycosis (South-American blastomycosis) is a disease
caused by the dimorphic fungus Paracoccidioides brasiliensis, which
was first described in 1908 by Lutz. Based on its pathogenesis the disease
may be classified in the following forms: regressive (asymptomatic
infection and primary pulmonary), progressive juvenile type (acute and
subacute; pulmonary or disseminated) and progressive adult type
(chronic; pulmonary or disseminated)4. Microscopic observation of P.
brasiliensis in clinical samples and its isolation in culture are the most
important diagnostic findings10. The double immunodiffusion and
complement fixation serologic tests applied to paracoccidioidomycosis,
which are the most commonly used, have allowed its early diagnosis
and made it possible to manage the disease appropriately8. Radiological
imaging of the skeleton, gastrointestinal tract and lungs have been used
in the diagnosis and follow-up of these patients1,2. Whole body gallium-
67 scintigraphy has not been used routinely in the diagnosis and follow-
up of patients with this disease.
The purpose of this report is to describe the whole body gallium-67
scintigraphic findings in a patient with paracoccidioidomycosis (juvenile
disseminated form), with an atypical clinical course.
CASE REPORT
A 26 year-old farm worker female was admitted to the Campinas
State University Hospital with a three-month history of abdominal pain,
fever and weight loss. She presented with left cervical, bilateral axillary
and inguinal lymphadenopathy and a 10x10 cm mass in the right upper
quadrant of the abdomen.
Chest radiograph was normal. Abdominal computed tomography
and ultrasound showed massive ascites, retroperitoneal adenomegaly and
thickening of the intestinal walls of the mid abdomen. Endoscopy
revealed a fistula with a purulent secretion between the first and second
portions of the duodenum.
Paracoccidioides brasiliensis was demonstrated in the direct
microscopic examination of the duodenal secretion and the duodenal
biopsy demonstrated Paracoccidioides brasiliensis (Fig. 1) as well as
active chronic duodenal infection. Direct Ziehl-Neelsen microscopic
examination was negative for acid-fast bacilli, and the Lowenstein-Jensen
culture was negative for M. tuberculosis. Gomori-Grocott smears stains
showed multiple budding yeast cells, characteristic of P. brasiliensis in
the fine needle aspiration biopsy of the cervical lymph node. The ELISA
anti-HIV serologic test was negative. The double immunodiffusion
serologic tests for paracoccidioidomycosis were always negative.
Whole body gallium-67 scintigraphy (Fig. 2) revealed increased
uptake in the abdomen, involving the peritoneum and intestinal wall,
and in the left posterior cervical lymph nodes. These findings were
interpreted as active disease.
Therapy was initiated with oral administration of sulfametoxazol-
trimetoprim. Initially there was a good response that was followed by a
significant clinical worsening. The patient presented several episodes of
ascites. She was hospitalized and submitted to multiple large-volume
paracenteses; cultures of the ascitic fluid were always negative for fungi
(including P. brasiliensis) and mycobacteria. Amphotericin B therapy
was started on (total dose: 4 g). Creatinine serum levels became high
and the patient began with a milky secretion attributed to the long term
use of metoclopramide. A new whole body gallium-67 scintigraphy (Fig.
3) demonstrated active disease in the lungs and abdomen. There was
also increased uptake of the radiotracer in the kidneys and breasts which
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Fig. 1 - Duodenal biopsy demonstrating: A) massive and confluent mesenteric adenomegaly; B) multiple fungic structures with criptosporulation (Paracoccidioidomycosis). GOMORI-
GROCOTT 40x.
A B
Fig. 2 - Whole-body gallium-67 scintigraphy (anterior and posterior views) obtained at the
diagnosis reveals markedly increased uptake in the abdomen (arrow heads) and a left posterior
cervical lymph node (arrow), interpreted as active disease in these areas.
Fig. 3 - Whole-body gallium-67 scintigraphy (anterior and posterior views) obtained after
the beginning of the treatment with amphotericin B and metoclopramide shows diffusely
increased tracer uptake in the kidneys (arrows), breasts (arrow heads), lungs and abdomen
(dotted arrows). The findings in the kidneys were interpreted as nephrotoxicity due to
amphotericin B, the increased uptake in the breasts as side-effects from metoclopramide (the
patient presented with milky secretion) and the uptake in the lungs and abdomen were
interpreted as active disease.
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Fig. 5 - Whole-body scintigraphy (anterior view) obtained 31 months after the diagnosis
show persistently increased uptake of gallium-67 in the abdomen (arrow head).
Fig. 4 - Whole-body scintigraphy (anterior view) obtained 20 months after the diagnosis
shows persistently increased uptake of gallium-67 in the lungs (arrows) and abdomen (arrow
head), indicating active infection.
were interpreted as nefrotoxicity caused by amphotericin B and
stimulation of the breasts by metoclopramide, respectively.
Two other gallium-67 whole body scintigraphies (Fig. 4,5), obtained
20 and 31 months after the diagnosis, showed persistently increased
uptake in the lungs and abdomen.
Thirty eight months after diagnosis and beginning of treatment, the
patient was submitted to an exploratory laparotomy which showed a
retroperitoneal mass. Biopsy demonstrated P. brasiliensis by Periodic
acid-Schiff stain and Gomori-Grocott techniques.
In spite of appropriate therapy, which also included the association
of itraconazole, the patient did not improve. The patient died 46 months
after the diagnosis with septicemia due to Candida albicans (three
positive blood cultures) and disseminated intravascular coagulation.
Necropsy demonstrated disseminated paracoccidioidomycosis, with
multiple spherical microorganisms and a large number of buds in the
lungs and mesenteric lymph nodes.
COMMENTS
Gallium-67 citrate is a radiopharmaceutical that shows increased
uptake in foci of inflammatory and infectious diseases and several
malignant tumors. Gallium-67 scintigraphy has proven useful in the
investigation of patients with fever of unknown origin, patients with
suspected osteomyelitis and patients with impaired
immunocompetence3,11,12. It accumulates in infections caused by pyogenic
bacteria, mycobacteria and fungi.
The use of gallium-67 scans in patients with paracoccidioidomycosis
and other mycosis has already been described5-7,9. GIORGI et al.9,
studying 13 patients with confirmed diagnosis of
paracoccidioidomycosis, have shown that whole body gallium-67
imaging is a useful tool for detection of suspected and unsuspected lesions
of paracoccidioidomycosis and helps to evaluate the response of the
disease to specific therapy. These authors have shown good correlation
between whole body gallium-67 scintigraphy and the clinical and
laboratory findings. In some cases whole body gallium-67 scintigraphy
was even more sensitive than the other methods for the diagnosis of
lesion sites (e.g. gallium-67 imaging detected a brain lesion in one of
the patients despite of normal CSF and neurologic examination; after
appropriate therapy the follow-up study was normal).
In this case report there was also a good correlation between gallium-
67 imaging and the clinical history and prognosis. The areas of
persistently increased tracer uptake correlated well with the patient’s
poor response to the treatment, which lead to her death.
RESUMO
Pesquisa de corpo inteiro com gálio-67 em uma paciente com
paracoccidioidomicose: relato de caso
Paciente do sexo feminino de 26 anos foi internada com dor
abdominal, febre e emagrecimento. A investigação clínico-laboratorial
estabeleceu o diagnóstico de paracoccidioidomicose. Os achados
cintilográficos com citrato de gálio-67 correlacionaram-se com o curso
clínico da paciente.
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